← Leaderboards
Jarrett Lindsay
University Of Pennsylvania
$125,760
Attributed
$125,760
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$125,760 · 1
By mechanism
F31$125,760 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kiran Musunuru$21,648,838
- Daniel J. Powell$8,015,334
- Helena Chang Chui$16,982,623
- Stephan A Grupp$7,570,044
- Lin Zhang$9,813,751
Others in their field
Other Emerging Leaders on “Alcam Gene”
- Jennifer Marie Coughlin · Johns Hopkins University$1,752,466
- Petra Hirsova · Mayo Clinic Rochester$1,735,008
- Rebecca Terilli Veenhuis · Johns Hopkins University$698,954
- Jaehyup Kim · Ut Southwestern Medical Center$656,870
- Rafal Kaminski · Temple Univ Of The Commonwealth$435,875
- Daniel Charytonowicz · Icahn School Of Medicine At Mount Sinai$198,020
Research focus
Alcam GeneAntibodiesAntibody-Drug ConjugatesAntigensBindingBioinformaticsBoneCancer Stem CellCell AdhesionCell Adhesion MoleculesCell GrowthCell LineCell MotilityCell SurfaceCell Surface ProteinsCell SurvivalChemotherapyChildChildhoodChip-SeqChromatin ModificationClinical TrialsColorectal CancerAdult
Grant awards (3)
Characterizing ALCAM as an oncoprotein and immunotherapeutic target in neuroblastoma$34,204
F31 · FY2022 · CA · contact PI
Characterizing ALCAM as an oncoprotein and immunotherapeutic target in neuroblastoma$46,036
F31 · FY2021 · CA · contact PI
Characterizing ALCAM as an oncoprotein and immunotherapeutic target in neuroblastoma$45,520
F31 · FY2020 · CA · contact PI